您的位置: 首页 > 外文期刊论文 > 详情页

Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

作   者:
Gorski, MathiasJung, BettinaLi, YongMatias-Garcia, Pamela R.Wuttke, MatthiasCoassin, StefanThio, Chris H. L.Kleber, Marcus E.Winkler, Thomas W.Wanner, VeronikaChai, Jin-FangChu, Audrey Y.Cocca, MassimilianoFeitosa, Mary F.Ghasemi, SaharHoppmann, AnselmHorn, KatrinLi, ManNutile, TeresaScholz, MarkusSieber, Karsten B.Teumer, AlexanderTin, AdrienneWang, JudyTayo, Bamidele O.Ahluwalia, Tarunveer S.Almgren, PeterBakker, Stephan J. L.Banas, BernhardBansal, NishaBiggs, Mary L.Boerwinkle, EricBottinger, Erwin P.Brenner, HermannCarroll, Robert J.Chalmers, JohnChee, Miao-LiChee, Miao-LingCheng, Ching-YuCoresh, Josefde Borst, Martin H.Degenhardt, FraukeEckardt, Kai-UweEndlich, KarlhansFranke, AndreFreitag-Wolf, SandraGampawar, PiyushGansevoort, Ron T.Ghanbari, MohsenGieger, ChristianHamet, PavelHo, KevinHofer, EdithHolleczek, BerndFoo, Valencia Hui XianHutri-Kahonen, NinaHwang, Shih-JenIkram, M. ArfanJosyula, Navya ShilpaKahonen, MikaKhor, Chiea-ChuenKoenig, WolfgangKramer, HollyKraemer, Bernhard K.Kuehnel, BrigitteLange, Leslie A.Lehtimaki, TerhoLieb, WolfgangLoos, Ruth J. F.Lukas, Mary AnnLyytikainen, Leo-PekkaMeisinger, ChristaMeitinger, ThomasMelander, OlleMilaneschi, YuriMishra, Pashupati P.Mononen, NinaMychaleckyj, Josyf C.Nadkarni, Girish N.Nauck, MatthiasNikus, KjellNing, BotingNolte, Ilja M.O'Donoghue, Michelle L.Orho-Melander, MarjuPendergrass, Sarah A.Penninx, Brenda W. J. H.Preuss, Michael H.Psaty, Bruce M.Raffield, Laura M.Raitakari, Olli T.Rettig, RainerRheinberger, MyriamRice, Kenneth M.Rosenkranz, Alexander R.Rossing, PeterRotter, Jerome, ISabanayagam, CharumathiSchmidt, HelenaSchmidt, ReinholdSchoettker, BenSchulz, Christina-Alexandra
作者机构:
Univ Groningen Singapore Dept Internal MedUniv Mississippi Memory Impairment & Neurodegenerat Dementia MIND Hypertens & Cardiovasc DisCardiovasc Hlth Res UnitUniv Texas Hlth Sci Ctr Houston Dept Clin Physiol Seattle Franz Josef Strauss Allee 11 Diabet & Cardiovasc Dis Genet Epidemiol New York Amsterdam Publ Hlth Dept Hlth ServFimlab LabsNatl Univ SingaporeHelmholtz Zentrum Munchen Anschutz Med Campus St Louis Dept Clin Sci Malmo MD USA Inst Epidemiol TX 77030 USA Netherlands Amsterdam Freiburg Inst Mol Biol & BiochemIRCCS Burlo Garofolo IL USATampere Univ Hosp Maywood MA 02115 USA Human Genet Ctr Leipzig Finland Saw Swee Hock Sch Publ Hlth BerlinMerck & Co Inc Jackson Inst Genet Epidemiol Sch Med Ctr Publ Hlth Genom Dept Nephrol & Med Intens CareGlaxoSmithKline Biomed & Translat Informat Inst Australia Genet Div NephrolGeisinger Inst Clin Mol Biol Tampere Nashville Res Unit Mol Epidemiol Inst Med Informat Stat & Epidemiol NC USA Sch Publ HlthUniv Colorado Denver FraminghamCNR Dept Epidemiol Dept BiostatNatl Univ Hlth Syst Dept MedChristian AlbrechtsUniv Kiel Clin Div Neurogeriatr Baltimore Dept Cardiol Med Fac Mannheim NY 10029 USA Dept Psychiat Chapel Hill Turku NM USA Greifswald Dept Publ Hlth Sci Inst Translat Genom & Populat Sci Innsbruck GermanySingapore Natl Eye CtrCHUM VA USAHarbor UCLA Med Ctr MontrealLund Univ BostonTech Univ MunichUniv N Carolina George Inst Global Hlth Deutsch Herzzentrum Munchen Human Genet Dept Biomed Informat Amsterdam UMC Charlottesville WA 98195 USAUniv Freiburg Kenilworth Rotterdam Dept Genet & PharmacolTurku Univ Hosp Groningen Houston Aurora Albuquerque Div Nephrol & Hypertens Dept NeurolWashington Univ MS 39216 USA PQ Med Ctr Dept Genet MO 63110 USANHLBIs Framingham Heart Study PA USA CollegevilleUniv Utah Div Clin Epidemiol & Aging ResSteno Diabet Ctr Copenhagen UT 84112 USA Fac MedHeidelberg Univ Salt Lake City KarlsburgUniv New South Wales Ctr Mol Med 75 Francis St Dept Biometry Epidemiol & Med BioinformatBrigham & Womens Hosp Cardiovasc Div TN USA Italy Div Biomed Informat & Personalized MedUniv Med Ctr Rotterdam Lundquist Inst Biomed Innovat Rockville German Res Ctr Environm Hlth Dept Med Nephrol Hypertensiol Rheumatol Endocrino Inst Maternal & Child Hlth GentofteUniv LeipzigBoston Univ Cardiovasc Hlth Res Unit Dept Clin ChemUniv VirginiaMed Univ InnsbruckGerman Canc Res Ctr Sweden Mannheim Neuherberg NJ USAGeisinger Res Inst Community Med NSW Kiel Sydney Div Stat Genom MA USA Dept Nephrol Partner Site Greifswald Montreal Univ Hosp Res CtrUniv Washington GrazVanderbilt Univ Partner Site Munich Heart Alliance Inst Physiol Univ Med Ctr GroningenDZHK German Ctr Cardiovasc Res DanvilleMed Univ Graz Target Sci Genet Naples Dept Clin Physiol & Nucl Med Inst Genet & Biophys Adriano Buzzati Traverso D-93053 RegensburgJohns Hopkins Bloomberg Sch Publ HlthCharite Univ Med Berlin Erasmus MCLoyola Univ Chicago Munich Singapore Eye Res InstVrije UnivUniv Hosp Regensburg Canada Independent Res Grp Clin Epidemiol Trieste Charles Bronfman Inst Personalized Med MalmoIcahn Sch Med Mt Sinai Inst Med Informat & Stat WA USA AustriaUniv Med Greifswald Univ Hosp Schleswig Holstein Dept Genet EpidemiolUniv RegensburgUniv Kiel Heidelberg Dept Pediat Kidney Hlth Res Inst KHRI Denmark
关键词:
end-stage kidney diseasegenome-wide association studyrapid eGFRcrea declineacute kidney injury
期刊名称:
Kidney international.
i s s n:
0085-2538
年卷期:
2021 年 99 卷 4 期
页   码:
926-939
页   码:
摘   要:
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
相关作者
载入中,请稍后...
相关机构
    载入中,请稍后...
应用推荐

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充